SWX:ABBN
SWX:ABBNElectrical

Is ABB (SWX:ABBN) Prioritizing Margin Over Growth in Its Latest Guidance Update?

At the Bloomberg New Economy Forum in Singapore, ABB recently reaffirmed its mid-term revenue growth target of 5–7% annually on a comparable basis and raised its operational earnings margin goal to 18–22%. While the increased profitability target marked a positive step, the decision not to lift sales growth guidance, despite stronger targets from peers, stood out to industry observers and investors. We'll examine how ABB's decision to maintain its sales growth target, even as peers raise...
SWX:UBXN
SWX:UBXNSemiconductor

Does u-blox Holding's (SWX:UBXN) Index Exit Reveal Shifts in Its Investor Appeal?

On November 18, 2025, u-blox Holding AG (SWX:UBXN) was removed from the S&P Global BMI Index, a widely tracked global benchmark for equities. This index exclusion can influence trading behavior, as passive funds often adjust their portfolios to align with index changes, potentially impacting liquidity. We'll now consider how the index removal and subsequent fund adjustments may shape u-blox Holding's broader investment narrative. We've found 15 US stocks that are forecast to pay a dividend...
SWX:SENS
SWX:SENSElectronic

High Growth Tech Stocks to Watch in November 2025

As global markets navigate the aftermath of the longest U.S. government shutdown in history, investors are observing mixed performances across major indices, with small-cap stocks particularly underperforming due to heightened sensitivity to interest rate movements and ongoing concerns about elevated valuations. In this environment, identifying high-growth tech stocks requires a focus on companies that can demonstrate resilience and adaptability amid economic uncertainties and shifting market...
SWX:GALD
SWX:GALDPharmaceuticals

Is Galderma's New Restylane Lyft Data and FDA Approval Reshaping Its Competitive Edge (SWX:GALD)?

Galderma recently presented new clinical data from its Restylane and Sculptra portfolios at the American Society for Dermatologic Surgery 2025 Annual Meeting in Chicago, including results that supported the recent FDA approval of Restylane Lyft for chin augmentation in adults. This new data not only highlights high patient satisfaction and durable results for the company’s injectable aesthetics but also addresses emerging needs among patients experiencing facial changes following...
SWX:GALE
SWX:GALEHealthcare

What Galenica (SWX:GALE)'s CHF 250 Million Bond Issuance Means For Shareholders

Earlier this month, Galenica AG announced the successful placement of a CHF 250 million fixed rate bond with a 7-year term and a 1.08% annual coupon, set to mature in 2032 and managed by UBS. This move enables Galenica to refinance bridge financing from its Labor Team Group acquisition, lowers short-term liabilities, and further strengthens its long-term capital structure. We will now examine how extending Galenica’s debt maturity profile through this bond may influence the company’s...
SWX:TEMN
SWX:TEMNSoftware

Could Temenos' (SWX:TEMN) US Innovation Push Reveal Its Strategy for Long-Term Competitive Edge?

Temenos was recently named a Leader in the IDC MarketScape for North America Retail Digital Banking Solutions 2025–2026, highlighting the company’s flexible architecture, scale, reliability, and robust ecosystem integration. In addition, Temenos launched its Innovation Hub in Central Florida, aiming to advance US banking solutions with transformative technologies like Generative AI. We'll explore how Temenos’ industry leadership positioning and AI-driven US innovation focus shapes its...
SWX:PSPN
SWX:PSPNReal Estate

Taking Stock of PSP Swiss Property (SWX:PSPN) Valuation After Mixed Q3 and Nine-Month 2025 Earnings

PSP Swiss Property (SWX:PSPN) just released its third quarter and nine-month 2025 earnings, drawing attention with a blend of steady sales, a dip in quarterly profit, and higher net income over nine months. See our latest analysis for PSP Swiss Property. PSP Swiss Property’s latest results arrive with the stock up 7.6% year-to-date, and a notably strong total shareholder return of nearly 16% over the past twelve months. The steady sales and uptick in nine-month net income appear to be keeping...
SWX:TECN
SWX:TECNLife Sciences

Tecan Group (SWX:TECN): Assessing Valuation After CFO Departure Announcement and Shifting Investor Sentiment

Tecan Group (SWX:TECN) has revealed that CFO Tania Micki will be leaving the company to pursue an external opportunity, with her planned departure scheduled for May 2026. This kind of transition, especially in a key financial role, often prompts investors to consider what it could mean for future strategy and company performance. See our latest analysis for Tecan Group. Following news of CFO Tania Micki’s planned departure, Tecan’s share price has continued its recent downward momentum,...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA) Valuation in Focus After New CHF 600 Million Bond Issue Boosts Financial Flexibility

Sika (SWX:SIKA) has completed a CHF 600 million bond issue across three tranches, attracting significant investor interest. The offering aims to bolster the company’s funding flexibility and assist in refinancing existing financial obligations. See our latest analysis for Sika. Amid the news of Sika’s successful bond placement, it is worth noting that momentum in the company’s shares has faded this year. The year-to-date share price return is -30.39%, and the 1-year total shareholder return...
SWX:DAE
SWX:DAEMachinery

Will Dätwyler Holding’s (SWX:DAE) Ambitious Margin Targets Reshape Its Long-Term Growth Narrative?

In a recent update, Dätwyler Holding AG announced new medium-term financial targets, projecting an EBIT margin above 17% and annual organic revenue growth in the higher single-digit percentage range. This guidance signals management’s increased confidence in both operational improvement and profitability, underlining the company's positive outlook for future performance. We'll examine how Dätwyler's ambitious margin target and growth expectations could influence the company's investment...
SWX:BARN
SWX:BARNFood

How Barry Callebaut's AI Collaboration With NotCo (SWX:BARN) Has Changed Its Investment Story

Barry Callebaut announced a collaboration with NotCo AI to integrate artificial intelligence into chocolate recipe development, combining Barry Callebaut’s expertise with NotCo’s proprietary AI platform to accelerate innovation and address sector challenges. This partnership signals a shift toward digital transformation in the chocolate industry, aiming to create more tailored, sustainable, and efficient solutions at scale. We’ll now explore how Barry Callebaut’s move into AI-powered...
SWX:YPSN
SWX:YPSNMedical Equipment

Will Surging Net Income Redefine Ypsomed Holding’s (SWX:YPSN) Investment Narrative?

Ypsomed Holding AG recently reported results for the half year ended September 30, 2025, revealing net income of CHF 139.09 million, up from CHF 32.6 million a year earlier, with basic and diluted earnings per share rising to CHF 10.19 from CHF 2.39. This sharp increase in profitability highlights the company's growing efficiency and operational momentum over the last year. With net income rising to CHF 139.09 million, we'll consider how this earnings surge influences Ypsomed Holding's...